FR3034023B1 - Dispositif de traitement cutane - Google Patents

Dispositif de traitement cutane Download PDF

Info

Publication number
FR3034023B1
FR3034023B1 FR1552380A FR1552380A FR3034023B1 FR 3034023 B1 FR3034023 B1 FR 3034023B1 FR 1552380 A FR1552380 A FR 1552380A FR 1552380 A FR1552380 A FR 1552380A FR 3034023 B1 FR3034023 B1 FR 3034023B1
Authority
FR
France
Prior art keywords
active layer
treatment device
skin treatment
layer
face
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1552380A
Other languages
English (en)
Other versions
FR3034023A1 (fr
Inventor
Jean-Laurent Houot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lucibel SA
Original Assignee
Lucibel SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lucibel SA filed Critical Lucibel SA
Priority to FR1552380A priority Critical patent/FR3034023B1/fr
Publication of FR3034023A1 publication Critical patent/FR3034023A1/fr
Application granted granted Critical
Publication of FR3034023B1 publication Critical patent/FR3034023B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/0616—Skin treatment other than tanning
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
    • A61N2005/0643—Applicators, probes irradiating specific body areas in close proximity
    • A61N2005/0645—Applicators worn by the patient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/065—Light sources therefor
    • A61N2005/0651—Diodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0662—Visible light
    • A61N2005/0663—Coloured light
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/062—Photodynamic therapy, i.e. excitation of an agent

Abstract

Le dispositif (10) est un patch comprenant une couche active (12) en matériau silicone incorporant un principe actif à effet cosmétique ou pharmaceutique. Cette couche (12) présente une face, dite face de contact (12A), destinée à venir en contact avec la peau d'un utilisateur et un substrat (14) en élastomère portant la couche active (12) et incorporant dans sa masse une source lumineuse (16) à diode électroluminescente (18) d'émission d'un flux lumineux au travers de la couche active (12). La couche active (12) est fixée de manière détachable au substrat (14) par des moyens de liaison amovibles complémentaires (26) aptes à rendre la couche active (12) interchangeable.
FR1552380A 2015-03-23 2015-03-23 Dispositif de traitement cutane Active FR3034023B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1552380A FR3034023B1 (fr) 2015-03-23 2015-03-23 Dispositif de traitement cutane

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1552380A FR3034023B1 (fr) 2015-03-23 2015-03-23 Dispositif de traitement cutane

Publications (2)

Publication Number Publication Date
FR3034023A1 FR3034023A1 (fr) 2016-09-30
FR3034023B1 true FR3034023B1 (fr) 2021-01-08

Family

ID=53404715

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1552380A Active FR3034023B1 (fr) 2015-03-23 2015-03-23 Dispositif de traitement cutane

Country Status (1)

Country Link
FR (1) FR3034023B1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3137298A1 (fr) 2022-07-04 2024-01-05 Lucibel Sa Insert diffusant la lumière pour le traitement par photothérapie

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060173514A1 (en) * 2005-02-02 2006-08-03 Advanced Photodynamic Technologies, Inc. Wound treatment device for photodynamic therapy and method of using same
US20070233208A1 (en) * 2006-03-28 2007-10-04 Eastman Kodak Company Light therapy bandage with imbedded emitters
WO2012130336A1 (fr) * 2011-03-29 2012-10-04 Principium Europe S.R.L. Libération de substances biologiquement actives de masse moléculaire élevée
FR2986156B1 (fr) * 2012-01-30 2014-07-04 Rhenovia Pharma Dispositif transdermique pour l'administration controlee a un patient d'au moins un principe actif

Also Published As

Publication number Publication date
FR3034023A1 (fr) 2016-09-30

Similar Documents

Publication Publication Date Title
AR118559A2 (es) Anticuerpos anti-pd-l1 y su uso para mejorar la función de las células t
Yan et al. Redox remodeling as an immunoregulatory strategy
EA201790443A1 (ru) Универсальный анализ коагуляции на основе микрожидкостного чипа
BR112019000474A2 (pt) dispositivo de aspersão com medição de fluxo
EA202091615A1 (ru) Интраназальные составы на основе эпинефрина и способы лечения заболевания
BR112017008265A2 (pt) dispositivo emissor de luz sem uso das mãos e sistema de crescimento capilar para uso em um couro cabeludo humano com cabelo
ITVA20110027A1 (it) Composizioni per la cura della persona
FR2999438B1 (fr) Capsule et dispositif de distribution d'un produit avec emission d'un rayonnement d'energie sous forme ondulatoire lumineuse
EA200800782A1 (ru) ПРОИЗВОДНЫЕ АМИДА И КАРБАМАТА N-{2-[4-АМИНО-2-(ЭТОКСИМЕТИЛ)-1Н-ИМИДАЗОЛО[4,5-c]ХИНОЛИН-1-IL]-1,1-ДИМЕТИЛЭТИЛ}МЕТАНСУЛЬФОНАМИДА И СПОСОБЫ
PE20151982A1 (es) Derivados de bencimidazolona como inhibidores del bromodominio
CL2014000171A1 (es) Compuestos derivados de tetrahidropirido-piridina y tetrahidropirido-pirimidina, moduladores de receptores de c5a; composicion farmaceutica que los comprende; combinacion farmaceutica; uso en el tratamiento de degeneracion macular relacionada con la edad, retinopatia diabetica, esclerosis multiple, ave, enfermedad de parkinson, enfermedad de crohn, entre otras.
BR112014028232A2 (pt) formulações para atração de inseto e controle de inseto
GT201700179A (es) Formulaciones en polvo nasal para el tratamiento de hipoglicemia
AR111360A1 (es) Tratamiento usando células t de receptor quimérico incorporando células t polifuncionales optimizadas
ATE389432T1 (de) Vorrichtung zur transdermalen verabreichung von wirkstoffen
FR2980343B1 (fr) Applicateur de produit cosmetique sur les levres d'un utilisateur et procede d'application associe
CO6640324A2 (es) Uso de metformina en combinación con un activador de glucoquinasa y composiciones que comprenden metformina y un activador de glucoquinasa
MA43767B1 (fr) Anticorps non antagonistes dirigés contre la chaine alpha du domaine extracellulaire du récepteur de l'il-7 et leur utilisation dans le traitement du cancer
CO2021016619A2 (es) Anticuerpos de receptor de péptido natriurético 1 y métodos de uso
Hanafi et al. Fludarabine downregulates indoleamine 2, 3-dioxygenase in tumors via a proteasome-mediated degradation mechanism
FR3034023B1 (fr) Dispositif de traitement cutane
CL2016001965A1 (es) Composición coadyuvante anticancerígena que contiene rip3 expresión del promotor como ingrediente activo, método para seleccionar composición coadyuvante anticancerígena para mejorar la sensibilidad de droga anticancerigena, promoviendo la expresión rip3, y metodo para seguimiento de sensibilidad; medicamento contra el cáncer
EA200900254A1 (ru) Производные 1h-индол-2-карбоновой кислоты, полезные в качестве модуляторов ppar
AR060312A1 (es) Metodos para regular renalasa (monoamina oxidasa c)
AR046729A1 (es) Concentrado de tienil-sulfonamidas para suspender en aceites

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20160930

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10